arrow
C

Chris Jones

Leeds Cancer Centre
H指数:85
被引数:3.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Treatment and outcomes of immunotherapy related colitis and hepatitis- a multi-centre cohort study in the United Kingdom by the National Oncology Trainee Collaborative for Healthcare Research (NOTCH)

免疫治疗相关结肠炎和肝炎的治疗与转归——英国国家肿瘤培训生医疗研究合作组织(NOTCH)开展的多中心队列研究

2026-05-290
OAAI
TIP-30. Molecularly-guided phase 2 umbrella trial for children and young adults with newly-diagnosed high-grade glioma (HGG) including diffuse intrinsic pontine glioma (DIPG): CONNECT TarGeT (Targeted pediatric HGG therapy) trial in progress

TIP-30. 分子引导的针对新诊断的高级别胶质瘤(HGG,包括弥漫性内生性脑桥胶质瘤(DIPG)的儿童及青少年患者的二期伞式临床试验:正在进行的CONNECT TarGeT(靶向儿科HGG疗法)试验。

2025-11-110
OA
A systematic study of molecular diagnosis, treatment, and prognosis in infant-type hemispheric glioma: An individual patient data meta-analysis of 164 patients

婴儿型半球胶质瘤的分子诊断、治疗及预后系统性研究:一项包含164例患者的个体患者数据荟萃分析

2025-11-080
OA
Combination of ALK2 and cholesterol targeting agents exploits linked genetic and metabolic dependencies in diffuse midline glioma

ALK2与胆固醇靶向剂的组合利用弥漫性中线胶质瘤中相互关联的遗传和代谢依赖性

2025-11-010
OAAI
Biological Medicines for Diffuse Intrinsic Pontine Gliomas (DIPG) Eradication (BIOMEDE). An International Randomized Phase II Biomarker-driven Platform Trial Comparing Three Targeted Therapies in Combination with Radiotherapy

弥漫性内生性脑桥胶质瘤(DIPG)清除的生物制剂(BIOMEDE)。一项国际性、随机化、II期、生物标志物驱动的平台试验,比较三种靶向疗法联合放射治疗的效果。

2025-11-010
OAAI
A PROGNOSTIC HUMAN BRAIN NETWORK FOR DIFFUSE MIDLINE GLIOMA

弥漫性中线胶质瘤的预后人脑网络

2025-09-020
OAAI
Germline analysis of an international cohort of pediatric diffuse midline glioma patients

对国际队列儿童弥漫性中线胶质瘤患者的生殖系分析

2025-03-120
PRE
An exceptionally rare case of a diffuse midline glioma with concomitant H3.1 K27M and G34R mutations in the HIST1H3C (H3C3) gene

弥漫性中线胶质瘤伴HIST1H3C (H3C3) 基因H3.1 K27M和G34R突变的罕见病例

2025-01-160
OAAI
Diffuse pediatric high-grade glioma of methylation-based RTK2A and RTK2B subclasses present distinct radiological and histomolecular features including Gliomatosis cerebri phenotype
2024-11-180
OAAI
MOLECULAR AND BIOLOGY CORRELATIVE RESULTS FROM THE PHASE 1B TRIAL OF UNESBULIN (PTC596) WITH RADIOTHERAPY IN CHILDREN NEWLY-DIAGNOSED WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) AND HIGH-GRADE GLIOMA (HGG): A REPORT FROM THE COLLABORATIVE NETWORK FOR NEURO-ONCOLOGY CLINICAL TRIALS (CONNECT)
2024-11-110
PRE
The Stratified Medicine Paediatrics programme for cancers of childhood: Cell free DNA and serial tumour sequencing identifies subtype specific evolution and epigenetic states

儿童癌症分层医学儿科计划: 无细胞DNA和连续肿瘤测序确定亚型特异性进化和表观遗传状态

2024-09-050
PRE
INFANT-TYPE HEMISPHERIC GLIOMA (IHG): AN INDIVIDUAL PATIENT DATA META-ANALYSIS

婴儿型半球胶质瘤 (IHG): 个体患者数据的META分析

2024-06-180
OAAI
IDH- AND H3-WILDTYPE HIGH-GRADE GLIOMAS OCCURRING IN TEENAGERS AND YOUNG ADULT PATIENTS COMPRISE NOVEL MOLECULAR SUBGROUPS

在青少年和年轻成人患者中发生的IDH和H3-WILDTYPE高级别神经胶质瘤包括新的分子亚组

2024-06-180
OAAI
PEDIATRIC PATIENTS WITH DIFFUSE MIDLINE GLIOMA DEMONSTRATE AN UNEXPECTED PREVALENCE OF GERMLINE VARIANTS IN HOMOLOGOUS RECOMBINATION GENES

弥漫性中线胶质瘤的儿科患者在同源重组基因中表现出意想不到的种系变异患病率

2024-06-180
OAAI
INTEGRATED MOLECULAR PROFILING OF >2000 PAEDIATRIC-TYPE DIFFUSE HIGH-GRADE GLIOMA TUMOURS AND >100 PATIENT-DERIVED MODELS

> 2000儿科型弥漫性高级别神经胶质瘤肿瘤和> 100患者衍生模型的综合分子谱分析

2024-06-180
OAAI
AN EXCEPTIONALLY RARE CASE OF A DIFFUSE MIDLINE GLIOMA WITH CONCOMITANT H3.1 K27M AND G34R MUTATIONS IN THEHIST1H3C (H3C3) GENE

弥漫性中线胶质瘤伴hist1h3c (H3C3) 基因H3.1 K27M和G34R突变的罕见病例

2024-06-180
OAAI
A NOVEL ROLE FOR ACVR1/ALK2 IN REGULATING CHOLESTEROL BIOSYNTHESIS PROVIDES A NEW COMBINATORIAL THERAPEUTIC APPROACH FOR PATIENTS WITH DMG

ACVR1/ALK2在调节胆固醇生物合成中的新作用为DMG患者提供了一种新的组合治疗方法

2024-06-180
OAAI